For the quarter ending 2026-03-31, HRMY made $215,387K in revenue. $31,729K in net income. Net profit margin of 14.73%.
| Income Statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Net product revenue | 215,387 | 243,776 | 239,455 | 200,489 |
| Cost of product sold | 44,512 | 68,545 | 59,650 | 38,153 |
| Gross profit | 170,875 | 175,231 | 179,805 | 162,336 |
| Research and development | 69,383 | 49,933 | 54,962 | 50,159 |
| Sales and marketing | 31,694 | 29,179 | 29,549 | 30,073 |
| General and administrative | 32,507 | 57,562 | 29,807 | 33,924 |
| Total operating expenses | 133,584 | 136,674 | 114,318 | 114,156 |
| Operating income | 37,291 | 38,557 | 65,487 | 48,180 |
| Other expense, net | -127 | -105 | -106 | -193 |
| Interest expense | 3,234 | 3,546 | 3,621 | 3,646 |
| Interest income | 5,757 | 5,854 | 5,730 | 5,296 |
| Income before income taxes | 39,687 | 40,760 | 67,490 | 49,637 |
| Income tax expense | 7,199 | 18,274 | 16,625 | 9,861 |
| Net income | 32,488 | 22,486 | 50,865 | 39,776 |
| Unrealized (gain) income on investments | -759 | -11 | 118 | -6 |
| Comprehensive income | 31,729 | 22,475 | 50,983 | 39,770 |
| Basic EPS | 0.56 | 0.39 | 0.88 | 0.69 |
| Diluted EPS | 0.55 | 0.384 | 0.87 | 0.68 |
| Basic Average Shares | 57,819,060 | 57,638,493 | 57,550,902 | 57,469,775 |
| Diluted Average Shares | 58,776,297 | 58,508,670 | 58,717,910 | 58,427,134 |
Harmony Biosciences Holdings, Inc. (HRMY)
Harmony Biosciences Holdings, Inc. (HRMY)